Bronchopleural Fistula Clinical Trial
Official title:
Umbilical Cord Mesenchymal Stem Cells for Treatment of Bronchopleural Fistula
Bronchopleural fistula (BF), an abnormal passage or communication between a bronchus and
another part of the body, may develop when there are penetrating wounds of the thorax and
after lung surgery. Without effective therapy, treatment of BF is a challenge, with a high
rate of mortality and teratogenicity.
The investigators will conduct endoscopic injection of umbilical cord mesenchymal stem cells
to fistula, observe the recovery of bronchopleural fistula and systemic reactions, to
investigate the application of umbilical cord mesenchymal stem cells in the treatment of
bronchopleural fistula.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04435249 -
ENgineered Tissue Repair of BronchopleUral fiSTula
|
Phase 1/Phase 2 | |
| Completed |
NCT01153074 -
Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device
|
N/A | |
| Completed |
NCT05304897 -
PRP Efficacy and Safety in BPF
|
N/A |